# 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)

> **NCT00144196** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 224 (—)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** tiotropium (Spiriva)

## Key facts

- **NCT ID:** NCT00144196
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03-11
- **Primary completion:** 2005-07-25
- **Final completion:** 2005-07-25
- **Target enrollment:** 224 (—)
- **Last updated:** 2023-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00144196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00144196, "12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00144196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*